⬅ Back to All Recalls

Biotrin Parvovirus B19 IgM Recall Due to The affected kit lot may cause inval...

# Major Recall Alert: Biotrin Parvovirus B19 IgM Recalled Due to Invalid Calibrations, False Negative Test Results, and Other Issues

The Biotrin Parvovirus B19 IgM diagnostic kit, a widely used tool in medical diagnostics, has been officially recalled as of **June 12, 2025**. The affected kit lot has raised major concerns due to issues such as **invalid calibrations, positive control out of range low, and false negative patient test results.** These flaws can jeopardize the accuracy of clinical diagnostics, posing potential health risks to patients. Here's everything you need to know about this critical recall and how to protect yourself.

## Why This Recall is Important

When it comes to diagnostic tools, **accuracy and reliability are paramount.** The Biotrin Parvovirus B19 IgM test kit is designed to detect the IgM antibodies associated with parvovirus B19 infections. However, the recalled lot may fail to provide reliable results, leading to serious consequences:

- **False negative results:** Patients who test negative could unknowingly carry the infection, delaying important diagnosis and treatment.
- **Calibration errors:** Labs may experience issues with invalid calibrations, making the test kit ineffective.
- **Positive controls out of range:** The kit may fail to work correctly during quality control processes, further undermining trust in its results.

This recall highlights a significant risk to laboratories, healthcare providers, and patients who depend on trustworthy diagnostic results. Using faulty kits could delay proper treatment or mislead public health responses.

## Details of the Recall

### Brand Name:
- **Biotrin**

### Product:
- **Biotrin Parvovirus B19 IgM**

### Recall Start Date:
- **June 12, 2025**

### Recall Reasons:
The affected kit lot has been found to cause:
- Invalid calibrations
- Positive control out of range low
- False negative patient test results

### Potential Risk:
- Missed or delayed diagnoses
- Inaccurate health assessments in patients
- Possible widespread implications in lab-based services

For more details on the recall, visit the official Canadian recall alert page here: [Official Recall Notice](https://recalls-rappels.canada.ca/en/alert-recall/biotrin-parvovirus-b19-igm-0).

## What You Should Do

If you are a laboratory professional, healthcare provider, or patient concerned about this recall, here’s what you need to do:

1. **Stop using the affected Biotrin Parvovirus B19 IgM kits immediately.** Review your inventory and identify if you have the affected lot.
2. **Contact the manufacturer or distributor** for guidance on returning the product and obtaining a replacement.
3. **Communicate with patients** who may have received tests using the faulty kit. Retesting may be required for accurate diagnosis.
4. **Monitor for updates** regarding this recall on trusted sources, such as the official recall page linked [here](https://recalls-rappels.canada.ca/en/alert-recall/biotrin-parvovirus-b19-igm-0).

## Stay Safe – Get Instant Recall Alerts

Recalls of diagnostic tools like the Biotrin Parvovirus B19 IgM test kit remind us of the importance of staying informed and vigilant. Don’t let vital safety alerts slip through the cracks!

For real-time updates about product recalls that affect your health and safety in **Canada**, download our app today. Our app provides:
- **Instant notifications** on the latest recalls
- Comprehensive details and steps to take
- Easy-to-use features to keep you and your loved ones safe

📲 **Take control of your safety now. [Download the app today](https://recalls-rappels.canada.ca/en/alert-recall/biotrin-parvovirus-b19-igm-0).**

Your health and safety should never be compromised. Act now, stay informed, and ensure you're always protected against potential risks.

⬅ Back to All Recalls